Total raised
—
Last: Seed 2018-09
Stage
Seed
Founded
2018
Headcount
4
HQ
Sector
Health Tech & Life Sciences
About
Ramino Bio is developing an oral drug to treat cardio-metabolic diseases and rare Maple Syrup Urine Disease (MSUD). Ramino Bio’s unique technology addresses the unmet need of several metabolic diseases in the emerging novel elevated BCAA (Branched-chain amino acid) field. With a druggable lead compound, showing efficacy in-vivo, Ramino Bio is heading preclinical stages. First-in-human studies are planned within 18 months with our lead candidate. We are committed to developing effective therapies for the benefit of the patients.
Funding history · 1 round · — total
2018-09
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Ramino-Bio's drug development?
- Ramino-Bio is developing an oral drug to treat cardio-metabolic diseases and the rare Maple Syrup Urine Disease (MSUD).
- When was Ramino-Bio founded?
- Ramino-Bio was founded in September 2018.
- What is the current operational status of Ramino-Bio?
- Ramino-Bio is currently inactive, having ceased operations in November 2025.
- Which investors participated in Ramino-Bio's Seed round?
- Ramino-Bio's Seed round in September 2018 included investors such as Johnson & Johnson Innovation, RMGP Biopharma Investment Fund, FutuRx, Israel Innovation Authority, OrbiMed, and Takeda Ventures.
- What is the current stage of Ramino-Bio's product development?
- Ramino-Bio's product is in the R&D stage, with the company heading preclinical stages and planning first-in-human studies within 18 months for its lead candidate.
- How many employees does Ramino-Bio have?
- Ramino-Bio has 4 employees.
- Does Ramino-Bio hold any patents?
- Yes, Ramino-Bio holds 1 patent.
- What is Ramino-Bio's primary sector?
- Ramino-Bio's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
rare-diseasesbiopharmaceuticaltreatmentspharmaceuticalsmetabolic-diseasedrug-developmentcardiovascularbiotechnology